STRATEC Biomedical AG (DE:SBS)
XETRA:SBS
Holding DE:SBS?
Track your performance easily

STRATEC Biomedical (SBS) Financial Statements

3 Followers

STRATEC Biomedical Financial Overview

STRATEC Biomedical's market cap is currently ―. The company's EPS TTM is €0.823; its P/E ratio is 38.98; and it has a dividend yield of 1.75%. STRATEC Biomedical is scheduled to report earnings on March 26, 2025, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 22Sep 22Jun 22Mar 22Dec 21
Income Statement-
Total Revenue€ 66.97M€ 70.46M€ 61.81M€ 75.39M€ 61.91M
Gross Profit€ 16.13M€ 25.53M€ 15.22M€ 22.62M€ 16.71M
EBIT€ 5.55M€ 16.11M€ 5.23M€ 14.10M€ 4.53M
EBITDA€ 9.82M€ 20.25M€ 9.38M€ 18.46M€ 8.85M
Net Income Common Stockholders€ 4.50M€ 12.12M€ 1.43M€ 11.17M€ 3.61M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments€ 24.07M€ 41.10M€ 50.28M€ 50.95M€ 48.72M
Total Assets€ 397.50M€ 398.54M€ 385.44M€ 386.91M€ 368.52M
Total Debt€ 87.15M€ 0.00€ 0.00€ 0.00€ 85.30M
Net Debt€ 63.08M€ -41.10M€ -50.28M€ -50.95M€ 36.57M
Total Liabilities-----
Stockholders Equity€ 225.18M€ 214.57M€ 204.41M€ 217.54M€ 205.76M
Cash Flow-
Free Cash Flow€ -18.88M€ -6.65M€ 19.95M€ -3.16M€ 8.12M
Operating Cash Flow€ -12.01M€ -2.47M€ 23.98M€ 773.00K€ 12.95M
Investing Cash Flow€ -2.08M€ -9.00M€ -4.01M€ -3.91M€ -4.78M
Financing Cash Flow€ 2.83M€ -1.99M€ -20.03M€ 5.09M€ -7.38M
Currency in EUR

STRATEC Biomedical Earnings and Revenue History

STRATEC Biomedical Debt to Assets

STRATEC Biomedical Cash Flow

STRATEC Biomedical Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis